Grieg Seafood ASA (GSF)
Oslo Stock Exchange · Norway · prices in NOK · close of 23 Oct 2026
Key indicators
| Last close | NOK 22.78 |
|---|---|
| 52-week range | 22.50 – 41.59 |
| Return, 1 month / 3 months | −11.2% / −24.4% |
| Return, 1 year / 3 years | −39.7% / −35.1% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 29.6% |
| Worst drawdown (1 year) | -45.1% |
| Average daily value traded | 10.72M NOK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Grieg Seafood is a salmon farming company based in Norway. It raises salmon at sea sites and in freshwater facilities, then processes and sells the fish as fresh or frozen products. Its customers are seafood buyers, processors and retailers in Europe and overseas, and it also runs farming operations in Canada and the United Kingdom. The company handles the whole chain from roe and smolt through harvesting and packing, supplying salmon to food markets around the world.
The shares are listed on the Oslo Stock Exchange in Norway under the code GSF, and the price on this page is in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Grieg Seafood ASA (GSF) trades on the Oslo Stock Exchange in Norway. It last closed at NOK 22.78 on 23 October 2026.
Its price-based Market X-Ray is 32 out of 100 (a weak price profile), ranking 222 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 39.7% and over the last three months it fell 24.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 12 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -29.4% | ||
| From 52-week high | -44.9% | ||
| Momentum | 13 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -24.4% | ||
| 6-month return | -33.7% | ||
| 12-month return, skipping the last month | -32.2% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.1% | ||
| Liquidity | 73 · Strong | Trades actively. | |
| Average daily value traded | 10.72M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −2.1% |
|---|---|
| 1 month | −11.2% |
| 3 months | −24.4% |
| 6 months | −33.7% |
| 1 year | −39.7% |
| 3 years | −35.1% |
| 5 years | −45.5% |
Signals
| 50-day / 200-day average | 26.04 / 32.28 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.61 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Apr 2026 | NOK 33.5905 |
| 20 Jun 2024 | NOK 1.7500 |
| 28 Jun 2023 | NOK 4.5000 |
| 9 Jun 2023 | NOK 4.5000 |
| 10 Jun 2022 | NOK 3.0000 |
| 25 Nov 2019 | NOK 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.